Table 5.
Trial arm | Retest uptake | n | % | Cost of retest component $ | Cost of overall retest pathway $ | Overall cost $ | No. of repeat infections | Cost per repeat infection $ |
---|---|---|---|---|---|---|---|---|
Clinic retest | No retest | 181 | 61 | 98.7a | 17864.7 | |||
Retest | 117 | 39 | 69.9 | 168.6 | 19726.2 | |||
Total | 298 | 37590.9 | 12 | 3132.6 | ||||
Home retest REACT study | No retest | 118 | 39 | 116.4b | 13735.2 | |||
Retest at home | 134 | 44 | 55.3 | 154.0 | 20636.0 | |||
Sent home kit but retested at the clinic | 50 | 17 | 186.3c | 9315.0 | ||||
Total | 302 | 43686.2 | 31 | 1409.2 |
aIncludes all costs in the clinic retest pathway except the retest component
bIncludes all costs in the home retest strategy except the laboratory fee
cIncludes all costs in the home retest strategy except the laboratory fee, plus the cost of the clinic retest component